Mary Shoemaker
Director/Board Member at TRAWS PHARMA, INC.
Net worth: 2 141 $ as of 2024-04-29
Mary Shoemaker active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TRAWS PHARMA, INC. | Director/Board Member | 2020-03-31 | - |
| Independent Dir/Board Member | 2020-03-31 | - |
Career history of Mary Shoemaker
Former positions of Mary Shoemaker
| Companies | Position | Start | End |
|---|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Corporate Officer/Principal | - | 2020-05-21 |
Medexus Pharma, Inc.
 Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Director/Board Member | 2018-09-30 | 2020-04-30 |
| Chief Executive Officer | 2011-12-31 | 2020-04-30 | |
| President | 2018-09-30 | 2020-04-30 | |
| INTERMUNE INC | Sales & Marketing | 2009-11-05 | 2010-06-30 |
Pharmion Corp.
 Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Corporate Officer/Principal | - | - |
Training of Mary Shoemaker
| Missouri State University | Undergraduate Degree |
| University of Central Missouri | Graduate Degree |
Statistics
International
| United States | 7 |
| Canada | 2 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Sales & Marketing | 1 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Health Technology |
| TRAWS PHARMA, INC. | Health Technology |
| Private companies | 3 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Medexus Pharma, Inc.
Medexus Pharma, Inc. Pharmaceuticals: MajorHealth Technology Medexus Pharma, Inc. develops treatments for autoimmune diseases. It focuses on development and commercialization of treatments for autoimmune diseases as well as cancer. The company was founded in 2012 and is headquartered in Chicago, IL. | Health Technology |
Pharmion Corp.
Pharmion Corp. Pharmaceuticals: MajorHealth Technology Pharmion Corp. engages in the development and commercialization of products for the treatment of hematology and oncology patients. It has operations in Switzerland, Israel, and Philippines. The company was founded by Patrick J. Mahaffy in 1999 and is headquartered in Boulder, CO. | Health Technology |
- Stock Market
- Insiders
- Mary Shoemaker
- Experience